Evidence map›Paper›PMID 7738195›Full record

ArticleThe Journal of clinical investigation1995

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat.

Y Zhang, K Nakata, M Weiden, W N Rom

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 183 citations in OpenAlex.

  1. Trial
  2. Article
  3. Vaccines · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Tuberculosis and HIV Coinfection.Cold Spring Harbor perspectives in medicine · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Y ZhangDepartment of Medicine, New York University Medical Center, New York 10016, USA.
K Nakata
M Weiden
W N Rom
University Medical Center · USNew York University · US

Funding

ZOPOLRESTAT IN SUBJECTS W/ PERIPHERAL SYMMETRICAL DIABETIC POLYNEUROPATHYM01RR000096 · NCRR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BORKOWSKY, WILLIAM · 1985 to 2008
$34.8M
EXAGGERATED RELEASE OF IL-1B AND TNF-A IN PULMONARY TBR01AI035233 · NIAID · NEW YORK UNIVERSITY · PI ROM, WILLIAM N · 1993 to 1995
–
CYTOKINES/ADHESION MOLECULES IN TB PATHOGENESISR01HL051494 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROM, WILLIAM N · 1994 to 1997
–
NCRR NIH HHS MO1 RR00096NHLBI NIH HHS HL-51494NIAID NIH HHS AI 35233
6 · The paper itself

Abstract

Tuberculosis has emerged as an epidemic fueled by the large number of individuals infected with the human immunodeficiency virus, especially those who are injecting drug users. We found a striking increase from 4- to 208-fold in p24 levels in bronchoalveolar lavage fluid from involved sites of Mycobacterium tuberculosis infection vs uninvolved sites in three HIV+ patients. We used an in vitro cell culture model to determine if tuberculosis could activate replication of HIV-1. Mononuclear phagocyte cell lines U937 and THP-1 infected with HIV-1JR-CSF, in vitro and stimulated with live M. tuberculosis H37Ra, had a threefold increase in p24 in culture supernatants. Using the HIV-1 long terminal repeat with a chloramphenicol acetyltransferase (CAT) reporter construct, live M. tuberculosis increased transcription 20-fold in THP-1 cells, and cell wall components stimulated CAT expression to a lesser extent. The nuclear factor-kappa B enhancer element was responsible for the majority of the increased CAT activity although two upstream nuclear factor-IL6 sites may also contribute to enhanced transcription. Antibodies to TNF-alpha and IL-1 inhibited the increase in CAT activity of the HIV-1 long terminal repeat by M. tuberculosis from 21-fold to 8-fold. Stimulation of HIV-1 replication by M. tuberculosis may exacerbate dysfunction of the host immune response in dually infected individuals.

Indexed as

HIV Long Terminal RepeatTranscriptional ActivationVirus ReplicationAdultAIDS-Related Opportunistic InfectionsAntibodiesBase SequenceCCAAT-Enhancer-Binding ProteinsCell LineCell NucleusChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsHIV-1HIV Core Protein p24HIV SeropositivityHumansAntibodiesCCAAT-Enhancer-Binding ProteinsChloramphenicol O-AcetyltransferaseDNA-Binding ProteinsHIV Core Protein p24Interleukin-1NF-kappa BNuclear ProteinsOligodeoxyribonucleotidesTranscription FactorsTumor Necrosis Factor-alpha

Identifiers

PMID7738195
PMCPMC295846
OpenAlexW2052260301

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.